Steven Cohen’s BridgeBio Pharma BBIO Stock Holding History

Steven Cohen’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114M	Buy	+1,525,782	New	+$107M	0.13%	172
2025 Q2	–	Sell	-198,780	Closed	-$6.87M	–	2182
2025 Q1	$6.87M	Buy	+198,780	New	+$6.7M	0.02%	816
2023 Q4	–	Sell	-5,265	Closed	-$158K	–	2170
2023 Q3	$139K	Sell	5,265 -61,409	-92%	-$1.74M	﹤0.01%	1875
2023 Q2	$1.15M	Sell	66,674 -32,500	-33%	-$489K	﹤0.01%	1122
2023 Q1	$1.64M	Buy	+99,174	New	+$1.16M	0.01%	1016
2022 Q1	–	Sell	-50,312	Closed	-$839K	–	1172
2021 Q4	$839K	Buy	+50,312	New	+$2.13M	﹤0.01%	936
2019 Q3	–	Sell	-13,200	Closed	-$356K	–	1142
2019 Q2	$356K	Buy	+13,200	New	+$360K	﹤0.01%	897

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Steven Cohen's BBIO Position: Q2 2026 in Review

Steven Cohen opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 1,525,782 shares worth $114M. The stake represents 0.13% of the portfolio and ranks #172 among its holdings. This is a return to the name: Steven Cohen previously reported a position in BBIO as recently as Q1 2025.

Steven Cohen first reported a position in BBIO in Q2 2019 and has held it in 7 quarters since. 471 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Steven Cohen held 1,525,782 shares of BridgeBio Pharma worth $114M as of Q2 2026.
BridgeBio Pharma was a new Steven Cohen position in Q2 2026.
BridgeBio Pharma made up 0.13% of Steven Cohen's portfolio in Q2 2026, its #172 holding.
Steven Cohen first reported a position in BridgeBio Pharma in Q2 2019 and has held it in 7 quarters since.
471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.